Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-24-000048
Filing Date
2024-08-09
Accepted
2024-08-09 16:15:37
Documents
98
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20240630x10q.htm   iXBRL 10-Q 2838618
2 EX-31.1 amph-20240630xex31d1.htm EX-31.1 19166
3 EX-31.2 amph-20240630xex31d2.htm EX-31.2 18821
4 EX-32.1 amph-20240630xex32d1.htm EX-32.1 9834
5 EX-32.2 amph-20240630xex32d2.htm EX-32.2 9835
  Complete submission text file 0001297184-24-000048.txt   11983512

Data Files

Seq Description Document Type Size
6 EX-101.SCH amph-20240630.xsd EX-101.SCH 66109
7 EX-101.CAL amph-20240630_cal.xml EX-101.CAL 69380
8 EX-101.DEF amph-20240630_def.xml EX-101.DEF 294218
9 EX-101.LAB amph-20240630_lab.xml EX-101.LAB 505235
10 EX-101.PRE amph-20240630_pre.xml EX-101.PRE 461584
101 EXTRACTED XBRL INSTANCE DOCUMENT amph-20240630x10q_htm.xml XML 2516017
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 241192991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)